BioNexus Gene Lab Corp..
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioNexus Gene Lab Corp..
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
/ 
Frequently asked questions
To buy BioNexus Gene Lab Corp.. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioNexus Gene Lab Corp.. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioNexus Gene Lab Corp.. is BGLC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioNexus Gene Lab Corp.. has its primary listing on NASDAQ (Small cap). You can trade BioNexus Gene Lab Corp.. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioNexus Gene Lab Corp.. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioNexus Gene Lab Corp.. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioNexus Gene Lab Corp...